Literature DB >> 9188650

Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21.

H Yoshiyama1, S Imai, N Shimizu, K Takada.   

Abstract

Recombinant Epstein-Barr virus (EBV) with a selectable marker successfully infected the human gastric carcinoma cell lines AGS, MKN28, and MKN74. Following incubation in selective media, drug-resistant cell clones were isolated and proved to be infected with EBV. All gastric carcinoma cell clones were positive for EBNA 1 but negative for EBNA 2. LMP 1 expression was negative in most clones, but there were a few exceptions. Gastric carcinoma cells were negative for the EBV receptor CD21, and infection was not inhibited by pretreatment of cells with the anti-CD21 monoclonal antibody OKB7. The results indicate that gastric carcinoma cells are susceptible to EBV infection and that infection is mediated via a new receptor different from CD21.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9188650      PMCID： PMC191818          DOI： 10.1128/JVI.71.7.5688-5691.1997

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  24 in total

1.  Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells.

Authors:  N Shimizu; H Yoshiyama; K Takada
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

2.  Epstein-Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in nonmalignant epithelial cells surrounded by EBV-positive T-lymphoma cells.

Authors:  S Wen; Y Mizugaki; F Shinozaki; K Takada
Journal:  Virology       Date:  1997-01-20       Impact factor: 3.616

3.  Association of Epstein-Barr virus with thymic carcinoma.

Authors:  S Leyvraz; W Henle; A P Chahinian; C Perlmann; G Klein; R E Gordon; M Rosenblum; J F Holland
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

4.  Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.

Authors:  N Shimizu; A Tanabe-Tochikura; Y Kuroiwa; K Takada
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Superinfection epithelial nasopharyngeal carcinoma cells with Epstein-Barr virus.

Authors:  R Glaser; G de Thé; G Lenoir; J H Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1976-03       Impact factor: 11.205

6.  Epstein-Barr virus replication in oropharyngeal epithelial cells.

Authors:  J W Sixbey; J G Nedrud; N Raab-Traub; R A Hanes; J S Pagano
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

7.  Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach.

Authors:  S C Barranco; C M Townsend; C Casartelli; B G Macik; N L Burger; W R Boerwinkle; W K Gourley
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

8.  Replication of Epstein-Barr virus in human epithelial cells infected in vitro.

Authors:  J W Sixbey; E H Vesterinen; J G Nedrud; N Raab-Traub; L A Walton; J S Pagano
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962

9.  Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression.

Authors:  H Yoshiyama; N Shimizu; K Takada
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

10.  Characterization of an Epstein-Barr virus receptor on human epithelial cells.

Authors:  M Birkenbach; X Tong; L E Bradbury; T F Tedder; E Kieff
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307
View more
  51 in total

1.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors:  A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 3.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

4.  Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.

Authors:  Chieko Noda; Takayuki Murata; Teru Kanda; Hironori Yoshiyama; Atsuko Sugimoto; Daisuke Kawashima; Shinichi Saito; Hiroki Isomura; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

5.  Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

6.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

7.  Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells.

Authors:  C M Borza; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 8.  Epstein-Barr virus is associated with gastric carcinoma: the question is what is the significance?

Authors:  Hugo Sousa; Ana-L Pinto-Correia; Rui Medeiros; Mario Dinis-Ribeiro
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

9.  Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells.

Authors:  X Wang; W J Kenyon; Q Li; J Müllberg; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection.

Authors:  Mohanan Valiya Veettil; Sathish Sadagopan; Neelam Sharma-Walia; Fu-Zhang Wang; Hari Raghu; Laszlo Varga; Bala Chandran
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.